107 related articles for article (PubMed ID: 1929397)
1. Identification and characterization of an NADPH-cytochrome P450 reductase derived peptide involved in binding to cytochrome P450.
Nadler SG; Strobel HW
Arch Biochem Biophys; 1991 Nov; 290(2):277-84. PubMed ID: 1929397
[TBL] [Abstract][Full Text] [Related]
2. The presence of essential carboxyl group for binding of cytochrome c in rat hepatic NADPH-cytochrome P-450 reductase by the reaction with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
Inano H; Tamaoki B
J Enzyme Inhib; 1985; 1(1):47-59. PubMed ID: 2854844
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide.
Roberts ES; Hopkins NE; Alworth WL; Hollenberg PF
Chem Res Toxicol; 1993; 6(4):470-9. PubMed ID: 8374044
[TBL] [Abstract][Full Text] [Related]
4. Identification of specific carboxyl groups on Anabaena PCC 7119 flavodoxin which are involved in the interaction with ferredoxin-NADP+ reductase.
Medina M; Peleato ML; Mendez E; Gomez-Moreno C
Eur J Biochem; 1992 Feb; 203(3):373-9. PubMed ID: 1735424
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of human cytochrome P450 2B6 to NADPH-cytochrome P450 reductase: Identification of a potential site of interaction.
Bumpus NN; Hollenberg PF
J Inorg Biochem; 2010 Apr; 104(4):485-8. PubMed ID: 20096935
[TBL] [Abstract][Full Text] [Related]
6. Role of lysine and arginine residues of cytochrome P450 in the interaction between cytochrome P4502B1 and NADPH-cytochrome P450 reductase.
Shen S; Strobel HW
Arch Biochem Biophys; 1993 Jul; 304(1):257-65. PubMed ID: 8323289
[TBL] [Abstract][Full Text] [Related]
7. Modification of carboxyl groups on NADPH-cytochrome P-450 reductase involved in binding of cytochromes c and P-450 LM2.
Bernhardt R; Pommerening K; Ruckpaul K
Biochem Int; 1987 May; 14(5):823-32. PubMed ID: 2841939
[TBL] [Abstract][Full Text] [Related]
8. Purification, characterization, and cDNA cloning of an NADPH-cytochrome P450 reductase from mung bean.
Shet MS; Sathasivan K; Arlotto MA; Mehdy MC; Estabrook RW
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2890-4. PubMed ID: 8464904
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptide mimics of a predicted topographical interaction surface: the cytochrome P450 2B1 recognition domain for NADPH-cytochrome P450 reductase.
Omata Y; Dai R; Smith SV; Robinson RC; Friedman FK
J Protein Chem; 2000 Jan; 19(1):23-32. PubMed ID: 10882169
[TBL] [Abstract][Full Text] [Related]
10. Studies on the cosubstrate site of protease solubilized NADPH-cytochrome P450 reductase.
Lumper L; Busch F; Dzelić S; Henning J; Lazar T
Int J Pept Protein Res; 1980 Jul; 16(1):83-96. PubMed ID: 6777326
[TBL] [Abstract][Full Text] [Related]
11. Purification and partial characterization of NADPH-cytochrome c reductase from Petunia hybrida flowers.
Menting JG; Cornish E; Scopes RK
Plant Physiol; 1994 Oct; 106(2):643-50. PubMed ID: 7991686
[TBL] [Abstract][Full Text] [Related]
12. Cloning and heterologous expression of NADPH-cytochrome P450 reductases from the Papaveraceae.
Rosco A; Pauli HH; Priesner W; Kutchan TM
Arch Biochem Biophys; 1997 Dec; 348(2):369-77. PubMed ID: 9434750
[TBL] [Abstract][Full Text] [Related]
13. Crosslinking of cytochrome c and cytochrome b5 with a water-soluble carbodiimide. Reaction conditions, product analysis and critique of the technique.
Mauk MR; Mauk AG
Eur J Biochem; 1989 Dec; 186(3):473-86. PubMed ID: 2558010
[TBL] [Abstract][Full Text] [Related]
14. Differential labeling of the catalytic subunit of cAMP-dependent protein kinase with a water-soluble carbodiimide: identification of carboxyl groups protected by MgATP and inhibitor peptides.
Buechler JA; Taylor SS
Biochemistry; 1990 Feb; 29(7):1937-43. PubMed ID: 2331473
[TBL] [Abstract][Full Text] [Related]
15. Identification of specific carboxylate groups on adrenodoxin that are involved in the interaction with adrenodoxin reductase.
Geren LM; O'Brien P; Stonehuerner J; Millett F
J Biol Chem; 1984 Feb; 259(4):2155-60. PubMed ID: 6365905
[TBL] [Abstract][Full Text] [Related]
16. Functional assessment of specific amino acid residues of cytochrome P4501A1 using anti-peptide antibodies.
Shen S; Strobel HW
Arch Biochem Biophys; 1995 Jun; 320(1):162-9. PubMed ID: 7793977
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the adenosinetriphosphatase activity of Escherichia coli F1 by the water-soluble carbodiimide 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide is due to modification of several carboxyls in the beta subunit.
Lötscher HR; deJong C; Capaldi RA
Biochemistry; 1984 Aug; 23(18):4134-40. PubMed ID: 6237683
[TBL] [Abstract][Full Text] [Related]
18. Probing the putative cytochrome P450- and cytochrome c-binding sites on NADPH-cytochrome P450 reductase by anti-peptide antibodies.
Shen S; Strobel HW
Biochemistry; 1994 Jul; 33(29):8807-12. PubMed ID: 8038172
[TBL] [Abstract][Full Text] [Related]
19. The role of cytochrome P450 lysine residues in the interaction between cytochrome P450IA1 and NADPH-cytochrome P450 reductase.
Shen S; Strobel HW
Arch Biochem Biophys; 1992 Apr; 294(1):83-90. PubMed ID: 1550361
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
